PDS Biotechnology Corp (PDSB)

Stammdaten

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclinical trials, including PDS0102 T-cell receptor gamma alternate reading frame protein (TARP) for treating prostate and breast cancers; PDS0103 (MUC-1) for ovarian, colorectal, lung, and breast cancers; and PDS0104, which include Tyrosinase-related protein 2 for the treatment of melanoma. In addition, it is developing PDS0201 for treating tuberculosis; PDS0202, an influenza vaccine candidate; and PDS0203, a vaccine for the prevention of COVID-19. The company has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey.

Unternehmen & Branche

NamePDS Biotechnology Corp
TickerPDSB
CIK0001472091
BoerseUS
SektorHealthcare
IndustrieBiotechnology

Wertpapier & Kennzahlen

CUSIP40765T107
ISINUS40765T1079
TypCommon Stock
Marktkapitalisierung60,3 Mio. USD
Beta1,19
Dividendenrendite0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2025-12-3110-K-34,495,505-0.7430,494,0839,251,833
2025-09-3010-Q-9,009,411-0.1934,705,8019,453,510
2025-09-3010-K-9,009,4119,453,510
2025-06-3010-K-9,434,20815,959,784
2025-06-3010-Q-9,434,208-0.2140,476,06515,959,784
2025-03-3110-K-8,488,96722,362,209
2025-03-3110-Q-8,488,967-0.2147,028,54222,362,209
2024-12-3110-K-7,952,352-1.0345,358,65719,004,848
2024-09-3010-K-10,726,65822,000,805
2024-09-3010-Q-10,726,658-0.2952,450,65322,000,805
2024-06-3010-Q-8,327,897-0.2360,495,94730,917,870
2024-06-3010-K-8,327,89730,917,870
2024-03-3110-Q-10,603,477-0.3069,006,36637,183,045
2024-03-3110-K-10,603,47737,183,045
2023-12-3110-K-10,898,216-1.3959,390,08026,130,947
2023-09-3010-Q-10,849,169-0.3557,187,82124,483,828
2023-09-3010-K-10,849,16924,483,828
2023-06-3010-K-11,534,89532,444,188
2023-06-3010-Q-11,534,895-0.3763,754,25032,444,188
2023-03-3110-Q-9,659,918-0.3268,448,62641,010,953

Fondsaktivität (Vorquartalsvergleich)

FondsAktuell (Stk)Vorquartal (Stk)Veränderung (Stk)Wert (USD)StatusΔTrend
VANGUARD GROUP INC1,950,94601,950,9461,502,228Neu+100,0%
BlackRock, Inc.522,2110522,211401,998Neu+100,0%
GEODE CAPITAL MANAGEMENT, LLC520,3980520,398400,666Neu+100,0%
UBS Group AG251,7050251,705193,812Neu+100,0%
BLAIR WILLIAM & CO/IL250,0000250,000192,450Neu+100,0%
COMMONWEALTH EQUITY SERVICES, LLC196,7970196,797151,490Neu+100,0%
Squarepoint Ops LLC192,5560192,556148,230Neu+100,0%
INSPIRION WEALTH ADVISORS, LLC180,4950180,495138,945Neu+100,0%
RENAISSANCE TECHNOLOGIES LLC176,7000176,700136,024Neu+100,0%
NORTHERN TRUST CORP143,8730143,873110,753Neu+100,0%
STATE STREET CORP133,3330133,333102,640Neu+100,0%
Iron Gate Global Advisors LLC75,016075,01657,747Neu+100,0%
Tempus Wealth Planning, LLC61,800061,80047,574Neu+100,0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP38,566038,56629,688Neu+100,0%
XTX Topco Ltd34,218034,21826,341Neu+100,0%
Rockefeller Capital Management L.P.25,664025,66419,756Neu+100,0%
SIMPLEX TRADING, LLC19,106019,10614,711Neu+100,0%
StoneX Group Inc.16,000016,00012,317Neu+100,0%
FIRST MANHATTAN CO. LLC.15,000015,00011,547Neu+100,0%
Federation des caisses Desjardins du Quebec14,800014,80011,396Neu+100,0%
Ground Swell Capital, LLC14,703014,70311,318Neu+100,0%
RAYMOND JAMES FINANCIAL INC13,736013,73610,574Neu+100,0%
DAVENPORT & Co LLC10,000010,0007,698Neu+100,0%
GRANDFIELD & DODD, LLC10,000010,0007,698Neu+100,0%
CITIGROUP INC9,39309,3937,231Neu+100,0%
WELLS FARGO & COMPANY/MN5,32905,3294,102Neu+100,0%
MORGAN STANLEY4,92204,9223,789Neu+100,0%
GROUP ONE TRADING LLC3,92203,9223,019Neu+100,0%
CREATIVE FINANCIAL DESIGNS INC /ADV3,00003,0002,309Neu+100,0%
Tower Research Capital LLC (TRC)2,22002,2201,709Neu+100,0%
JONES FINANCIAL COMPANIES LLLP2,00002,0001,538Neu+100,0%
BANK OF AMERICA CORP /DE/1,02801,028791Neu+100,0%
Truvestments Capital LLC6550655504Neu+100,0%
BNP PARIBAS FINANCIAL MARKETS6480648499Neu+100,0%
SBI Securities Co., Ltd.109010984Neu+100,0%
Virtu Financial LLC32,099032,09925Neu+100,0%
JPMORGAN CHASE & CO1901915Neu+100,0%
OSAIC HOLDINGS, INC.1701713Neu+100,0%
Wealth Group, Ltd.13,399013,39910Neu+100,0%
ROYAL BANK OF CANADA650650Neu+100,0%

Insider-Transaktionen (12 Monate)

Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.

Top-Fondshalter

Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.

FondsAnteileWert (USD)Anteil (%)
VANGUARD GROUP INC1,950,9461,502,22839.81
BlackRock, Inc.522,211401,99810.65
GEODE CAPITAL MANAGEMENT, LLC520,398400,66610.62
UBS Group AG251,705193,8125.14
BLAIR WILLIAM & CO/IL250,000192,4505.10
COMMONWEALTH EQUITY SERVICES, LLC196,797151,4904.01
Squarepoint Ops LLC192,556148,2303.93
INSPIRION WEALTH ADVISORS, LLC180,495138,9453.68
RENAISSANCE TECHNOLOGIES LLC176,700136,0243.60
NORTHERN TRUST CORP143,873110,7532.94
STATE STREET CORP133,333102,6402.72
Iron Gate Global Advisors LLC75,01657,7471.53
Tempus Wealth Planning, LLC61,80047,5741.26
SUSQUEHANNA INTERNATIONAL GROUP, LLP38,56629,6880.79
XTX Topco Ltd34,21826,3410.70
Rockefeller Capital Management L.P.25,66419,7560.52
SIMPLEX TRADING, LLC19,10614,7110.39
StoneX Group Inc.16,00012,3170.33
FIRST MANHATTAN CO. LLC.15,00011,5470.31
Federation des caisses Desjardins du Quebec14,80011,3960.30

Hinweis

Erweitert ×